SHERYL LEAHEY: Open Payments
NPI 1952869281 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 12 payments from 8 companies in 2025. Trend: 2023 $1,118 · 2024 $303 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $113 |
| Legend Biotech USA Inc. | 2 | $74 |
| PFIZER INC. | 1 | $40 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Genentech USA, Inc. | 1 | $29 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
Products named: CARVYKTI, DARZALEX, ELREXFIO, BLENREP, Fabhalta, Venclexta, TAVALISSE, Vanflyta.
Industry payments across CA — which companies pay providers there.
